A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Conditions : Metabolic Dysfunction-associated Steatohepatitis Interventions : Drug: Efimosfermin alfa; Drug: Placebo Sponsors : GlaxoSmithKline Not yet recruiting